Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
0.6984
+0.00 (0.00%)
NASDAQ · Last Trade: Jul 15th, 7:46 AM EDT
Via Benzinga · July 14, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · July 14, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · July 14, 2025
Via Benzinga · July 14, 2025
Via Benzinga · July 14, 2025

Via Benzinga · June 5, 2025
Via Benzinga · May 22, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · May 16, 2025

These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.
Via Stocktwits · February 10, 2025

Unusual volume stocks in Friday's session
Via Chartmill · February 7, 2025

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · February 6, 2025

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Via Chartmill · February 6, 2025

Via Benzinga · February 6, 2025

Via Benzinga · February 6, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 5, 2025

U.S. stock futures rose on Thursday following Wednesday's advances as investors digest tariff pauses amid earnings reports.
Via Benzinga · February 6, 2025

Rani Therapeutics shares are trading lower by 23% Tuesday afternoon. The company announced a $10 million direct offering of 3 million shares at $3 per share.
Via Benzinga · October 15, 2024

Via Benzinga · October 15, 2024

Via Benzinga · October 15, 2024

Via Benzinga · October 14, 2024

Via Benzinga · October 14, 2024